Aldosterone To Renin Ratio Calculator

Use this premium ARR calculator to estimate the aldosterone-renin ratio from common laboratory units and review a practical screening interpretation for suspected primary aldosteronism. This tool is educational and supports clinical discussion, but final interpretation depends on assay type, medication effects, posture, potassium status, sodium intake, and confirmatory testing.

Calculator

Expert Guide to the Aldosterone to Renin Ratio Calculator

The aldosterone to renin ratio, commonly shortened to ARR, is one of the most widely used screening tools for primary aldosteronism. Primary aldosteronism is a condition in which the adrenal glands produce too much aldosterone relative to the body’s renin signal. Excess aldosterone promotes sodium retention, potassium loss, and volume expansion, which can drive persistent hypertension and increase cardiovascular risk. Because many patients with resistant or unexplained hypertension remain undiagnosed for years, the ARR has become a practical first step when clinicians suspect an endocrine cause of high blood pressure.

This aldosterone to renin ratio calculator is designed to simplify the arithmetic while keeping the clinical context visible. The tool lets you enter aldosterone in ng/dL or pmol/L and renin as either plasma renin activity, abbreviated PRA, in ng/mL/h, or direct renin concentration, abbreviated DRC, in mU/L. Once the values are entered, the calculator computes the ratio and gives a screening-oriented interpretation. It also highlights key limitations, because ARR is not a stand-alone diagnostic test. A “high” ratio can support suspicion for primary aldosteronism, but diagnosis typically requires proper pretest preparation, repeat measurement if needed, and often confirmatory testing plus subtype evaluation.

What the ARR actually measures

Aldosterone is a mineralocorticoid hormone produced by the adrenal cortex. Under normal physiology, aldosterone secretion is stimulated by the renin-angiotensin system, potassium balance, and to a lesser extent adrenocorticotropic hormone. Renin, secreted by the kidney, is part of a hormonal cascade that signals the body to preserve blood pressure and sodium. In healthy feedback regulation, aldosterone and renin move in a coordinated fashion. In primary aldosteronism, aldosterone secretion becomes relatively autonomous. As aldosterone rises, renin is often suppressed. That combination, elevated aldosterone with low renin, is exactly why the ARR can be a powerful screening index.

A ratio is especially useful because it captures the relationship between both measurements rather than considering either in isolation. For example, an aldosterone level that appears only modestly elevated can still be clinically suspicious if renin is profoundly suppressed. Conversely, a patient with an elevated aldosterone value but also a high renin level may have secondary hyperaldosteronism instead of primary aldosteronism. The ratio therefore helps distinguish physiologic activation from inappropriate autonomous secretion.

How this calculator computes the ratio

In the most familiar convention, ARR is calculated as aldosterone in ng/dL divided by plasma renin activity in ng/mL/h. A common screening threshold often cited in practice is approximately 20 to 30, though interpretation varies by institution, assay, collection method, and whether there is a minimum aldosterone level requirement. Some centers prefer a threshold above 30 with aldosterone above 15 ng/dL; others use different combinations. If direct renin concentration is used instead of PRA, the numerical cutoffs are not interchangeable. DRC-based ARR thresholds are assay-specific and often lower in absolute number, sometimes around 2 to 5 when aldosterone is expressed in ng/dL and renin in mU/L, but local lab references are essential.

This calculator uses practical educational thresholds: for PRA-based ARR, less than 20 is generally lower suspicion, 20 to less than 30 is borderline, and 30 or more is elevated for screening discussion. For DRC-based ARR, less than 2 is generally lower suspicion, 2 to less than 5 is borderline, and 5 or more is elevated. These are not universal diagnostic cutoffs.

For unit conversion, the calculator uses a standard approximation of 1 ng/dL aldosterone = 27.74 pmol/L. If aldosterone is entered in pmol/L, it is converted back to ng/dL before the ratio is computed. This keeps the calculation consistent and easy to compare with commonly published screening approaches. Because DRC assays vary across laboratories, the DRC pathway should always be interpreted with local assay documentation and institutional guidance.

Who should be considered for ARR screening?

Screening is especially relevant when the clinical picture suggests excess mineralocorticoid activity. Professional societies often recommend considering primary aldosteronism in patients with resistant hypertension, severe hypertension, hypertension with spontaneous or diuretic-induced hypokalemia, hypertension with an adrenal incidentaloma, obstructive sleep apnea with hypertension, or a family history of early-onset hypertension or stroke. Screening may also be appropriate when hypertension is difficult to control despite multiple medications, because primary aldosteronism is substantially more common in resistant hypertension than in the general hypertensive population.

• Resistant hypertension requiring three or more medications
• Hypertension with unexplained hypokalemia
• Stage 2 or severe hypertension at a younger age
• Hypertension with an adrenal mass
• Family history of early cardiovascular events or known primary aldosteronism
• Hypertension plus sleep apnea or incidentally low renin states

Why numbers alone are not enough

The ARR is highly sensitive to preanalytic conditions. A patient’s posture matters because aldosterone and renin can differ between supine and upright sampling. Potassium status matters because hypokalemia can suppress aldosterone secretion, potentially masking disease. Sodium intake influences the renin-angiotensin-aldosterone axis, and so do many common antihypertensive drugs. Mineralocorticoid receptor antagonists such as spironolactone and eplerenone can significantly alter testing. Diuretics, beta blockers, ACE inhibitors, ARBs, central alpha-2 agonists, NSAIDs, oral contraceptives, and some calcium channel blockers may also shift renin or aldosterone enough to affect interpretation.

That is why an apparently normal result may be less reassuring when potassium is low, renin-altering medications are present, or the sampling conditions were suboptimal. Likewise, a high ratio is more convincing when renin is truly suppressed and aldosterone is above a minimum threshold rather than merely producing a large ratio from an extremely tiny denominator. Good screening practice focuses not just on the ratio itself, but on the pattern of both individual hormone values and the clinical setting.

Comparison of common ARR approaches

Approach	Aldosterone Unit	Renin Measure	Illustrative Screening Threshold	Practical Notes
PRA-based ARR	ng/dL	Plasma renin activity, ng/mL/h	Often around 20 to 30, commonly with a minimum aldosterone such as 10 to 15 ng/dL	Most widely taught format; thresholds vary by center and sample protocol.
DRC-based ARR	ng/dL or pmol/L	Direct renin concentration, mU/L or similar	Often around 2 to 5 when aldosterone is in ng/dL and renin in mU/L	Assay-specific; local laboratory cutoffs are essential.
Expanded interpretation	Any standardized unit set	PRA or DRC	Ratio plus suppressed renin plus inappropriately high aldosterone	Best reflects clinical reality and reduces misleading results.

What prevalence data tells us

Interest in ARR testing has grown because primary aldosteronism is more common than previously believed. Older teaching framed it as a rare cause of hypertension, but modern studies have shown a much broader prevalence spectrum. Reported prevalence depends on patient selection, assay method, and confirmatory protocol, yet the overall trend is clear: it is not rare in specialty hypertension practice.

Population	Reported Prevalence Range of Primary Aldosteronism	Clinical Meaning
General hypertension clinics	Approximately 3% to 13%	Enough to justify consideration in selected hypertensive patients, especially when renin is suppressed.
Resistant hypertension	Approximately 10% to 20% or higher in some referral series	ARR screening is particularly important because the yield is substantially greater.
Hypertension with hypokalemia	Higher than average, often markedly enriched	A low potassium level strongly raises suspicion and should prompt careful evaluation.

These ranges are representative of published clinical literature and guideline discussions rather than a universal fixed estimate. The key takeaway is that ARR screening has practical value because the condition is common enough to matter and treatable enough to change outcomes.

Interpreting a high ARR result

If the calculator shows a high ARR, the next question is not “Does the patient definitely have primary aldosteronism?” but rather “How strong is the screening signal, and are the testing conditions valid?” A convincing screening pattern usually includes:

1. Suppressed renin or very low renin activity
2. Aldosterone that is not merely detectable, but inappropriately elevated for the patient’s volume status
3. A ratio above the local screening threshold
4. Collection conditions that are compatible with interpretation
5. Clinical features such as resistant hypertension, hypokalemia, or adrenal imaging findings

When that pattern is present, clinicians typically proceed to confirmatory testing unless the presentation is so classic that guidelines allow a more direct path to subtype evaluation. Confirmatory options may include saline infusion testing, oral sodium loading, captopril challenge testing, or fludrocortisone suppression protocols, depending on local expertise. Once biochemical confirmation is established, imaging and often adrenal venous sampling help distinguish unilateral disease, which may be surgically curable, from bilateral disease, which is usually treated medically.

Interpreting a normal or borderline ARR result

A lower ratio does not automatically exclude disease. Borderline values can occur in patients taking interfering medications or in those whose aldosterone secretion is variable. A patient with a strong clinical phenotype may still need retesting after optimization of potassium and medications. Similarly, if renin is not suppressed, the ratio may be less informative, and the broader clinical context becomes even more important. The calculator’s “borderline” category is meant to encourage review rather than to label the result as normal.

Medication and preparation issues to review before testing

• Correct hypokalemia whenever possible before repeating measurements.
• Document posture, time of day, and sodium intake conditions.
• Review beta blockers, diuretics, ACE inhibitors, ARBs, mineralocorticoid receptor antagonists, and oral contraceptives.
• Use the local laboratory’s reference intervals and assay-specific decision limits.
• Interpret the absolute aldosterone value and the degree of renin suppression, not only the ratio.

How to use this calculator responsibly

This calculator is best used as a structured aid for understanding and communicating the ARR. Enter the laboratory values exactly as reported, select the correct units, then review both the ratio and the narrative interpretation. If the ratio is high, note whether the potassium status was low and whether posture was upright or supine, because both can affect confidence in the screening result. If direct renin concentration is used, be especially cautious and compare the result with local laboratory guidance because DRC assays are less interchangeable than PRA-based reporting.

For patients and readers, the most important message is that a high ARR is not a diagnosis by itself. It is a signal to discuss targeted evaluation with a qualified clinician, often in internal medicine, endocrinology, nephrology, or hypertension specialty care. For clinicians, the most important reminder is that ARR performs best when standardized conditions are respected and the result is integrated with the patient’s blood pressure pattern, potassium, medication list, kidney function, and confirmatory testing pathway.

Authoritative sources for further reading

National Heart, Lung, and Blood Institute (.gov)
National Institute of Diabetes and Digestive and Kidney Diseases (.gov)
Educational endocrine references from academic and specialty sources

For a more formal evidence base, readers can also review academic endocrinology materials from major university medical centers and society guidelines used by endocrine specialists. When possible, compare ARR results against your own institution’s assay reference sheet, since assay calibration and reporting units remain one of the biggest reasons that ARR thresholds vary across publications.